DK2204187T3 - Human influenzavaccine indeholdende fire influenzapeptider - Google Patents
Human influenzavaccine indeholdende fire influenzapeptiderInfo
- Publication number
- DK2204187T3 DK2204187T3 DK10003160.8T DK10003160T DK2204187T3 DK 2204187 T3 DK2204187 T3 DK 2204187T3 DK 10003160 T DK10003160 T DK 10003160T DK 2204187 T3 DK2204187 T3 DK 2204187T3
- Authority
- DK
- Denmark
- Prior art keywords
- influenza
- epitopes
- human
- epitope
- peptides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12733198A IL127331A0 (en) | 1998-11-30 | 1998-11-30 | Peptide-based vaccine for influenza |
EP99972929A EP1135159A2 (en) | 1998-11-30 | 1999-11-28 | Peptide-based vaccine for influenza |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2204187T3 true DK2204187T3 (da) | 2012-08-20 |
Family
ID=11072200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK10003160.8T DK2204187T3 (da) | 1998-11-30 | 1999-11-28 | Human influenzavaccine indeholdende fire influenzapeptider |
Country Status (15)
Country | Link |
---|---|
US (3) | US6740325B1 (da) |
EP (2) | EP2204187B1 (da) |
JP (1) | JP2002531415A (da) |
KR (1) | KR100703571B1 (da) |
AT (1) | ATE556719T1 (da) |
AU (1) | AU766883B2 (da) |
BR (1) | BR9915811A (da) |
CA (1) | CA2352454C (da) |
DK (1) | DK2204187T3 (da) |
ES (1) | ES2389611T3 (da) |
HK (2) | HK1040620A1 (da) |
IL (3) | IL127331A0 (da) |
NZ (1) | NZ511918A (da) |
PT (1) | PT2204187E (da) |
WO (1) | WO2000032228A2 (da) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL127331A0 (en) * | 1998-11-30 | 1999-09-22 | Yeda Res & Dev | Peptide-based vaccine for influenza |
AU2002223398A1 (en) * | 2000-08-10 | 2002-04-08 | Tsinghua University | A vaccine for influenza virus and its preparation |
FI20031536A0 (fi) * | 2003-10-20 | 2003-10-20 | Biotie Therapies Oyj | Korkean affiniteetin ligandit influenssavirukselle ja menetelmät niiden valmistamiseen |
ES2427847T3 (es) | 2003-11-04 | 2013-11-04 | The Administrators Of The Tulane Educational Fund | Método para prevenir la fusión virus:célula mediante la inhibición de la función de la región de iniciación de la fusión en virus de ARN que tienen proteínas de envuelta fusogénicas de membrana de clase I |
GB0716992D0 (en) * | 2007-08-31 | 2007-10-10 | Immune Targeting Systems Its L | Influenza antigen delivery vectors and constructs |
AU2006203985A1 (en) * | 2005-01-05 | 2006-07-13 | Philadelphia Health And Education Corporation | Delivery vehicles, bioactive substances and viral vaccines |
AU2006206647C1 (en) | 2005-01-19 | 2011-01-20 | Vaxinnate Corporation | Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response |
FI20060200A0 (fi) * | 2005-04-20 | 2006-02-27 | Glykos Finland Oy | Menetelmä ihmisen influenssaviruksen sialihahappositoumisspesifisyyden analysoimiseksi |
US20090104216A1 (en) * | 2005-06-01 | 2009-04-23 | Variation Biotechnologies, Inc. | Peptide-Based Influenza Vaccine Formulation |
US7871626B2 (en) | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
US7468187B2 (en) * | 2005-10-18 | 2008-12-23 | Iowa State University Research Foundation, Inc. | Canine influenza virus and related compositions and methods of use |
US20090169576A1 (en) * | 2005-10-26 | 2009-07-02 | Roberto Crea | Influenza combinatorial antigen vaccine |
JP2009514536A (ja) * | 2005-11-07 | 2009-04-09 | シドニー キンメル キャンサー センター | Cd40リガンド融合蛋白質ワクチン |
CA2632483C (en) | 2005-12-06 | 2014-11-25 | Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science | Improved influenza vaccine |
US20110027314A1 (en) * | 2006-01-27 | 2011-02-03 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | Influenza Vaccines Containing Hemagglutinin and Matrix Proteins |
GB0613977D0 (en) | 2006-02-07 | 2006-08-23 | Peptcell Ltd | Peptide sequences and compositions |
EP2476432B1 (en) | 2006-03-07 | 2015-08-19 | Vaxinnate Corporation | Compositions that include hemagglutinin, methods of making and methods of use thereof |
US20080208486A1 (en) * | 2006-03-23 | 2008-08-28 | Jari Natunen | Integrated System, Device and Use Thereof |
US8222204B2 (en) | 2006-05-03 | 2012-07-17 | The Administrators of the Tulane Educational Fund and Autoimmune Technologies, LLC | Influenza inhibiting compositions and methods |
WO2008002663A2 (en) * | 2006-06-28 | 2008-01-03 | The Board Of Trustees Of The Leland Stanford Junior University | Immunogenic protein constructs |
FI20060946A0 (fi) * | 2006-10-26 | 2006-10-26 | Glykos Finland Oy | Influenssaviruksen nukleiinihappoja ja peptidejä |
EP2139908A4 (en) | 2007-03-12 | 2011-02-16 | Antigen Express Inc | REMOVAL OF PROTEIN Li INVOLVED IN Li-RNAi CONSTRUCTIONS IN ANTICANCER IMMUNOTHERAPY |
WO2009016639A2 (en) | 2007-08-02 | 2009-02-05 | Biondvax Pharmaceuticals Ltd. | Multimeric multiepitope influenza vaccines |
EP2280991B1 (en) | 2008-04-18 | 2016-06-22 | VaxInnate Corporation | Deletion mutants of flagellin and methods of use |
EP2278997B1 (en) | 2008-04-21 | 2016-08-10 | Nanobio Corporation | Nanoemulsion influenza vaccine |
WO2009130618A2 (en) * | 2008-04-25 | 2009-10-29 | Institute For Systems Biology | Flagellin polypeptide vaccines |
CN102084252B (zh) | 2008-05-02 | 2017-03-22 | 罗切斯特大学 | 用于流感免疫应答测量的阵列检测器*** |
WO2010144797A2 (en) | 2009-06-12 | 2010-12-16 | Vaccine Technologies, Incorporated | Influenza vaccines with enhanced immunogenicity and uses thereof |
BR112012000826B1 (pt) | 2009-07-06 | 2022-07-26 | Variation Biotechnologies Inc | Método para a preparação de vesículas |
US9907746B2 (en) | 2009-07-06 | 2018-03-06 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
US9610248B2 (en) | 2010-07-06 | 2017-04-04 | Variation Biotechnologies, Inc. | Compositions and methods for treating influenza |
CN103501811B (zh) | 2011-01-13 | 2016-03-30 | 变异生物技术公司 | 用于治疗病毒感染的组合物和方法 |
CN107296792B (zh) | 2011-01-13 | 2021-07-27 | 变异生物技术公司 | 囊泡及由其产生之制剂的制备方法 |
US9303070B2 (en) | 2011-02-22 | 2016-04-05 | Biondvax Pharmaceuticals Ltd. | Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines |
WO2013006797A1 (en) | 2011-07-06 | 2013-01-10 | Nanobio Corporation | Human respiratory syncytial virus vaccine |
CA2845872C (en) | 2011-08-22 | 2023-03-28 | Nanobio Corporation | Herpes simplex virus nanoemulsion vaccine |
WO2013072768A2 (en) | 2011-11-18 | 2013-05-23 | Variation Biotechnologies, Inc. | Synthetic derivatives of mpl and uses thereof |
CN104302323A (zh) | 2012-01-12 | 2015-01-21 | 变异生物技术公司 | 用于治疗病毒感染的组合物和方法 |
RU2698906C2 (ru) | 2012-01-27 | 2019-09-02 | Вэриэйшн Биотекнолоджиз, Инк. | Способы и композиции для терапевтических агентов |
US8932598B2 (en) | 2012-08-28 | 2015-01-13 | Vaxinnate Corporation | Fusion proteins and methods of use |
JP2014169278A (ja) | 2013-02-05 | 2014-09-18 | Nitto Denko Corp | 経皮投与用ワクチン組成物 |
CA2840941A1 (en) | 2013-02-05 | 2014-08-05 | Nitto Denko Corporation | Wt1 peptide cancer vaccine composition for transdermal administration |
RU2014102945A (ru) | 2013-02-05 | 2015-08-10 | Нитто Денко Корпорейшн | Вакцинная композиция |
JP2014169275A (ja) | 2013-02-05 | 2014-09-18 | Nitto Denko Corp | 粘膜投与用ワクチン組成物 |
IN2014CH00395A (da) | 2013-02-05 | 2015-04-03 | Nitto Denko Corp | |
CN103961700A (zh) * | 2013-02-05 | 2014-08-06 | 日东电工株式会社 | 粘膜给予用疫苗组合物 |
KR20140100417A (ko) | 2013-02-05 | 2014-08-14 | 닛토덴코 가부시키가이샤 | 경피 투여용 백신 조성물 |
KR102045029B1 (ko) | 2013-02-05 | 2019-11-14 | 닛토덴코 가부시키가이샤 | 점막 투여용 wt1 펩티드 암 백신 조성물 |
CN103961307B (zh) | 2013-02-05 | 2019-11-29 | 日东电工株式会社 | 经皮给予用wt1肽癌症疫苗组合物 |
CA2841014A1 (en) | 2013-02-05 | 2014-08-05 | Nitto Denko Corporation | Tape preparation of wt1 peptide cancer vaccine for transdermal administration |
RU2531235C2 (ru) * | 2013-02-15 | 2014-10-20 | Общество с ограниченной ответственностью "Универсальные БиоСистемы" (ООО "УБС") | Поливалентная вакцина против гриппа на основе гибридного белка |
CN103901202B (zh) * | 2014-04-04 | 2015-08-12 | 中国人民解放军***疾病预防控制中心 | 基于共有表位甲型流感病毒抗体通用型竞争性elisa检测方法 |
US10925936B2 (en) | 2014-09-03 | 2021-02-23 | Nitto Denko Corporation | Vaccine pharmaceutical composition for cell-mediated immunity containing bisphosphonates |
US10471141B2 (en) | 2014-09-03 | 2019-11-12 | Nitto Denko Corporation | Bisphosphonate-containing vaccine pharmaceutical composition for humoral immunity |
US11278616B2 (en) | 2015-08-06 | 2022-03-22 | Nitto Denko Corporation | Immunity induction promoting composition, and vaccine pharmaceutical composition |
CN111148528A (zh) | 2016-12-28 | 2020-05-12 | 英福瓦克思公司 | 流感疫苗 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL61904A (en) | 1981-01-13 | 1985-07-31 | Yeda Res & Dev | Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same |
IL101639A0 (en) * | 1992-04-17 | 1992-12-30 | Yeda Res & Dev | Recombinant influenza vaccines |
AU3036597A (en) * | 1996-05-21 | 1997-12-09 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cells |
IL127331A0 (en) * | 1998-11-30 | 1999-09-22 | Yeda Res & Dev | Peptide-based vaccine for influenza |
-
1998
- 1998-11-30 IL IL12733198A patent/IL127331A0/xx unknown
-
1999
- 1999-11-28 DK DK10003160.8T patent/DK2204187T3/da active
- 1999-11-28 PT PT10003160T patent/PT2204187E/pt unknown
- 1999-11-28 EP EP10003160A patent/EP2204187B1/en not_active Expired - Lifetime
- 1999-11-28 ES ES10003160T patent/ES2389611T3/es not_active Expired - Lifetime
- 1999-11-28 WO PCT/IL1999/000640 patent/WO2000032228A2/en active IP Right Grant
- 1999-11-28 AU AU14066/00A patent/AU766883B2/en not_active Expired
- 1999-11-28 BR BR9915811-6A patent/BR9915811A/pt not_active IP Right Cessation
- 1999-11-28 US US09/856,920 patent/US6740325B1/en not_active Expired - Lifetime
- 1999-11-28 NZ NZ511918A patent/NZ511918A/en not_active IP Right Cessation
- 1999-11-28 EP EP99972929A patent/EP1135159A2/en not_active Withdrawn
- 1999-11-28 IL IL14336799A patent/IL143367A0/xx active IP Right Grant
- 1999-11-28 AT AT10003160T patent/ATE556719T1/de active
- 1999-11-28 KR KR1020017006639A patent/KR100703571B1/ko active IP Right Grant
- 1999-11-28 CA CA2352454A patent/CA2352454C/en not_active Expired - Lifetime
- 1999-11-28 JP JP2000584919A patent/JP2002531415A/ja active Pending
-
2001
- 2001-05-24 IL IL143367A patent/IL143367A/en not_active IP Right Cessation
-
2002
- 2002-03-19 HK HK02102105.6A patent/HK1040620A1/zh unknown
-
2004
- 2004-05-17 US US10/846,548 patent/US7192595B2/en not_active Expired - Lifetime
-
2007
- 2007-02-07 US US11/672,429 patent/US7514086B2/en not_active Expired - Fee Related
-
2010
- 2010-12-21 HK HK10111907.7A patent/HK1145448A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP2204187B1 (en) | 2012-05-09 |
CA2352454C (en) | 2013-02-05 |
NZ511918A (en) | 2003-08-29 |
AU766883B2 (en) | 2003-10-23 |
US20070122424A1 (en) | 2007-05-31 |
US7192595B2 (en) | 2007-03-20 |
HK1040620A1 (zh) | 2002-06-21 |
IL143367A (en) | 2006-09-05 |
AU1406600A (en) | 2000-06-19 |
ATE556719T1 (de) | 2012-05-15 |
KR20010089512A (ko) | 2001-10-06 |
BR9915811A (pt) | 2001-08-21 |
US20050002954A1 (en) | 2005-01-06 |
IL143367A0 (en) | 2002-04-21 |
US7514086B2 (en) | 2009-04-07 |
WO2000032228A3 (en) | 2000-10-05 |
PT2204187E (pt) | 2012-08-10 |
KR100703571B1 (ko) | 2007-04-05 |
US6740325B1 (en) | 2004-05-25 |
WO2000032228A2 (en) | 2000-06-08 |
CA2352454A1 (en) | 2000-06-08 |
HK1145448A1 (en) | 2011-04-21 |
ES2389611T3 (es) | 2012-10-29 |
EP1135159A2 (en) | 2001-09-26 |
EP2204187A1 (en) | 2010-07-07 |
IL127331A0 (en) | 1999-09-22 |
JP2002531415A (ja) | 2002-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2204187T3 (da) | Human influenzavaccine indeholdende fire influenzapeptider | |
JP2002531415A5 (da) | ||
Liu et al. | High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity | |
Schild et al. | Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide. | |
ES2619332T3 (es) | Fosfatasa alcalina dirigida al hueso, kits y métodos de uso de la misma | |
ES2721172T3 (es) | Una nueva clase de moléculas terapéuticas a base de proteínas | |
AR008765A1 (es) | Un peptido o un derivado, analogo o variante, funcional del mismo, un peptido recombinante o sintetico del mismo, una secuencia nucleotidica y vectorque la contiene, una celula huesped transformada, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un compuesto del | |
AR038568A1 (es) | Anticuerpos anti-a beta y su uso | |
ATE277633T1 (de) | Präparate und verfahren zum auslösen von ctl- immunität | |
RS51602B (sr) | April receptor (bcma) i njegova upotreba | |
ES2121830T3 (es) | Procedimiento para la preparacion a escala industrial de un concentrado de factor de willebrand humano normalizado de pureza muy elevada apropiado para uso terapeutico. | |
NO880494L (no) | Syntetiske nonapeptid- og decapeptidanaloger av lhrh som er anvendelige som lhrh-antagonister. | |
BRPI0519705A2 (pt) | composiÇÕes, proteÍnas de fusço e mÉtodos de estimular uma resposta imune em um indivÍduo | |
NO990533L (no) | GnRH-leukotoksin kimµrer | |
DE69939327D1 (de) | Funktionelle antagonisten von hedgehog-aktivität | |
ZA936629B (en) | Potentiation of immunogenic response | |
Hackett et al. | A synthetic decapeptide of influenza virus hemagglutinin elicits helper T cells with the same fine recognition specificities as occur in response to whole virus. | |
ES2127294T3 (es) | Vacunas del virus de la inmunodeficiencia anti-felino (fiv). | |
Wabuke-Bunoti et al. | Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin. | |
ES2171086T3 (es) | Uso de proteinas hmg para la preparacion de medicamentos con actividad citotoxica. | |
DK0707473T3 (da) | Orale farmaceutiske præparater omfattende et protein eller et peptid, et antistof og polymerkugler | |
DE60036692D1 (de) | Zusammensetzungen und methoden zur detektion einer trypanosoma cruzi infektion | |
DE69527708D1 (de) | Synthetischer impfstoff zum schutz gegen infektionen mit dem menschlichen immunschwächevirus | |
ATE208421T1 (de) | Stimulierung der immunantwort durch virales protein | |
Cole et al. | T cell recognition of the immunodominant Sendai virus NP324-332/Kb epitope is focused on the center of the peptide. |